Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCity Lon Inv Regulatory News (CLIG)

Share Price Information for City Lon Inv (CLIG)

Share Price is delayed by 15 minutes
Get Live Data
460.00    12.00 (2.68%)
Bid:
452.00
Ask:
457.00
Spread: 5.00 (1.106%)
Market Cap: £227.11m
CLIG Live PriceLast checked at - London Stock Exchange

Intraday City Lon Inv Share Chart

Director/PDMR Shareholding

24 Sep 2007 15:38

City of London Investment Group PLC24 September 2007 City of London Investment Group plc("the Company") 24 September 2007 Director Shareholding The Company was today informed that on 24 September 2007 Doug Allison (FinanceDirector) exercised options over 52,500 Ordinary Shares of 1p each in theCompany ("Ordinary Shares") held by the City of London Employee Share OptionTrust ("the ESOP"). The exercise price paid by Mr. Allison was 45p per OrdinaryShare. As a result of this transaction, Mr. Allison is now interested in228,125 Ordinary Shares representing 0.85% of the issued share capital and thereremain 2,150,625 Ordinary Shares held in the ESOP representing 8.03% of theissued share capital. Enquiries: Doug Allison (Finance Director)City of London Investment Group PLCTel: 020 7860 8347 Fred Walsh/Simon BrownLandsbanki Securities (UK) LimitedNominated Adviser & BrokerTel: 020 7426 9000 Simon Hudson/Andrew DunnTavistock Communications LtdTel: 0207 920 3150 This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
10th Oct 20175:27 pmRNSHolding(s) in Company
10th Oct 201712:20 pmRNSDirector/PDMR Shareholding
9th Oct 20177:00 amRNSAGM Trading Update
3rd Oct 20174:12 pmRNSHolding(s) in Company
28th Sep 20174:30 pmRNSHolding(s) in Company
22nd Sep 201711:08 amRNSHolding(s) in Company
18th Sep 20177:00 amRNSFinal Results
8th Sep 20177:53 amRNSDirector/PDMR Shareholding
31st Aug 20174:00 pmRNSOpen letter to the board of icapital.biz Berhad
20th Jul 20176:22 pmRNSHolding(s) in Company
19th Jul 20177:00 amRNSTrading Update
13th Jul 20176:15 pmRNSHolding(s) in Company
13th Jul 20177:00 amRNSChange of announcement date
13th Jun 20174:26 pmRNSBoard Changes
26th May 20173:49 pmRNSDirector/PDMR Shareholding
25th May 20172:12 pmRNSDirector/PDMR Shareholding
22nd May 201712:56 pmRNSHolding(s) in Company
8th May 20176:03 pmRNSShare Buyback and Total Voting Rights
26th Apr 20173:37 pmRNSHolding(s) in Company
18th Apr 20171:56 pmRNSDirector/PDMR Shareholding
11th Apr 20177:00 amRNSTrading Update
3rd Apr 201712:42 pmRNSHolding(s) in Company
24th Mar 20172:28 pmRNSHolding(s) in Company
21st Mar 20175:20 pmRNSHolding(s) in Company
22nd Feb 20171:40 pmRNSDirector/PDMR Shareholding
22nd Feb 20171:37 pmRNSDirector/PDMR Shareholding
20th Feb 20177:46 amRNSHALF YEAR RESULTS TO 31ST DECEMBER 2016
24th Jan 20173:24 pmRNSHardman Research:Q2 statement robust profitability
17th Jan 20177:00 amRNSFunds Under Management - Trading Update
24th Nov 20163:42 pmRNSDirector/PDMR Shareholding
19th Oct 201611:15 amRNSAGM resolutions
17th Oct 20165:49 pmRNSResult of AGM
13th Oct 20163:05 pmRNSDirector/PDMR Shareholding
11th Oct 20165:13 pmRNSHolding(s) in Company
11th Oct 20162:51 pmRNSDirector/PDMR Shareholding
10th Oct 20167:46 amRNSAGM Trading Update - 1st Qtr Funds under Mgmt
15th Sep 20169:46 amRNSLetter to icapital.biz Berhad
14th Sep 20169:32 amRNSHardman Report: Exchange rate moves give big boost
12th Sep 20167:00 amRNSFINAL RESULTS FOR THE YEAR TO 30TH JUNE 2016
18th Jul 20167:00 amRNSTrading Update
1st Jul 20167:00 amRNSBlock listing cancellation & block listing return
30th Jun 20164:40 pmRNSSecond Price Monitoring Extn
30th Jun 20164:35 pmRNSPrice Monitoring Extension
23rd Jun 20165:55 pmRNSDirector/PDMR Shareholding
14th Apr 201612:38 pmRNSHardman & Co Issues Research Report
22nd Feb 201611:18 amRNSDirector/PDMR Shareholding
15th Feb 20167:00 amRNSHalf Yearly Report
5th Feb 20164:40 pmRNSSecond Price Monitoring Extn
5th Feb 20164:35 pmRNSPrice Monitoring Extension
29th Jan 20164:41 pmRNSSecond Price Monitoring Extn

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.